News AbbVie's Venclyxto approved in Europe in CLL AbbVie blood cancer drug tipped to be a blockbuster.
News Digital NHS glaucoma device wins AbbVie innovation award Icare HOME lets patients measure internal eye pressure associated with glaucoma.
News Ablynx in talks with partners for RA drug Biotech suffered setback after AbbVie decided against partnership.
News AbbVie taking on Gilead with eight-week hep C course Latest combination drug resulted in 97.5% cure rates across all major disease strains
News GSK/Janssen's rheumatoid arthritis drug filed in EU Drug could compete against Sanofi rival if approved.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
